Nam Tai Property News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

12.01.22	Pre-market Movers: IMRN, PIK, NTP, FLUX, MCMJ… (RTTNews)
29.11.21	Nam Tai Provided an Update Regarding the Requisitioned Meeting (PR Newswire)
25.11.21	Nam Tai Responds to a Request to Call Special Meeting of Shareholders (PR Newswire)
17.11.21	Nam Tai Urges Shareholders to Vote for the Current Board and Support the Management (PR Newswire)
11.11.21	Nam Tai Issues Statement regarding the Hearing of Three Applications Filed Subsequent to the Appeal Judgment Dated October 4, 2021 (PR Newswire)
04.11.21	NAM TAI PROPERTY INC. Announces Q3 2021 Results (PR Newswire)
07.10.21	Nam Tai Issues Statement in Connection with its Appeal Against the Judgment dated March 3, 2021 (PR Newswire)
04.10.21	Nam Tai Issues Statement in Connection with its Appeal Against the Judgment dated March 3, 2021 (PR Newswire)
14.09.21	Nam Tai Property Inc. Secured a Loan Facility of Approximately US$164 Million to Address Its Liquidity Issues (PR Newswire)
06.08.21	Nam Tai Property Announces the Commencement of Pre-sale of Nam Tai Longxi (PR Newswire)
29.07.21	NAM TAI PROPERTY INC. Announces Q2 2021 Results (PR Newswire)
14.09.20	Stock Alert: Nam Tai Property Shares Hit 52-Week High (RTTNews)
20.06.18	NAM TAI PROPERTY INC. Announces Date of Report of Second Quarter 2018 Results and Payment of Quarterly Dividend (PR Newswire)
18.06.18	NeuroVive Out-licenses Targeted LHON Therapy to BridgeBio Pharma's New Subsidiary Fortify Therapeutics (PR Newswire)
18.06.18	NeuroVive Out-licenses Targeted LHON Therapy to BridgeBio Pharma's New Subsidiary Fortify Therapeutics (PR Newswire)
18.06.18	NeuroVive Out-licenses Targeted LHON Therapy to BridgeBio Pharma's New Subsidiary Fortify Therapeutics (PR Newswire)
01.06.18	Nam Tai Property Inc. Announces Results of 2018 Annual General Meeting (PR Newswire)
31.05.18	NAM TAI PROPERTY INC. Announces the Receipt of Construction Permits for Nam Tai Inno Park (PR Newswire)
23.05.18	Nam Tai Property Inc. Announces the Selection of Main Contractors for Nam Tai Inno Park (PR Newswire)
22.05.18	NeuroVive Pharmaceutical AB Interim Report January - March 2018 (PR Newswire)
22.05.18	NeuroVive Pharmaceutical AB Interim Report January - March 2018 (PR Newswire)
22.05.18	NeuroVive Pharmaceutical AB Interim Report January - March 2018 (PR Newswire)
02.05.18	NeuroVive Initiates Collaboration With Leading US TBI Research Organization (PR Newswire)
02.05.18	NeuroVive Initiates Collaboration With Leading US TBI Research Organization (PR Newswire)
02.05.18	NeuroVive Initiates Collaboration With Leading US TBI Research Organization (PR Newswire)
30.04.18	Nam Tai Property Inc. Reports Q1 2018 Results (PR Newswire)
27.04.18	Amendment: Resolutions From Annual General Meeting in NeuroVive Pharmaceutical AB (publ) (PR Newswire)
27.04.18	Amendment: Resolutions From Annual General Meeting in NeuroVive Pharmaceutical AB (publ) (PR Newswire)
27.04.18	Amendment: Resolutions From Annual General Meeting in NeuroVive Pharmaceutical AB (publ) (PR Newswire)
26.04.18	Global Cloud Robotics Market Report 2018-2022: Market to Grow by Over 20% - Key Vendors are Boston Scientific, Medtronic, Sorin, St. Jude Medical & Terumo (PR Newswire)
20.04.18	NeuroVive Presents NVP025 Mitochondrial Myopathy Project Progress at Mitochondrial Medicine Conference (PR Newswire)
20.04.18	NeuroVive Presents NVP025 Mitochondrial Myopathy Project Progress at Mitochondrial Medicine Conference (PR Newswire)
20.04.18	NeuroVive Presents NVP025 Mitochondrial Myopathy Project Progress at Mitochondrial Medicine Conference (PR Newswire)
17.04.18	NeuroVive's Partner Yungjin Pharm Completes KL1333 Phase I Study Recruitment (PR Newswire)
17.04.18	NeuroVive's Partner Yungjin Pharm Completes KL1333 Phase I Study Recruitment (PR Newswire)
17.04.18	NeuroVive's Partner Yungjin Pharm Completes KL1333 Phase I Study Recruitment (PR Newswire)
11.04.18	Nam Tai Property Inc. Announces Date of Report of First Quarter 2018 Results and Payment of Quarterly Dividend (PR Newswire)
10.04.18	Nam Tai Property Inc. Announces Financing Package for the Construction of Nam Tai Inno Park and Date of Earnings Release (PR Newswire)
16.03.18	Nam Tai Property Inc. Filed Annual Report on Form 20-F for 2017 with SEC on March 9, 2018 (PR Newswire)
15.02.18	NeuroVive Decides on a Rights Issue for Continued Drug Development (PR Newswire)
15.02.18	NeuroVive Decides on a Rights Issue for Continued Drug Development (PR Newswire)
15.02.18	NeuroVive Decides on a Rights Issue for Continued Drug Development (PR Newswire)
29.01.18	NeuroVive Reports Breakthrough in Mitochondrial Myopathy Project (PR Newswire)
29.01.18	NeuroVive Reports Breakthrough in Mitochondrial Myopathy Project (PR Newswire)
29.01.18	NeuroVive Reports Breakthrough in Mitochondrial Myopathy Project (PR Newswire)
29.01.18	Nam Tai Property Inc. Reports Q4 2017 Results (PR Newswire)
24.01.18	Napster Names Venesa Hoffmann as Vice President Business Development & Operations, EMEA (PR Newswire)
03.01.18	NeuroVive to Present at the 10th Annual Biotech Showcase Conference (PR Newswire)
03.01.18	NeuroVive to Present at the 10th Annual Biotech Showcase Conference (PR Newswire)
03.01.18	NeuroVive to Present at the 10th Annual Biotech Showcase Conference (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.75	0.89 %	K V
Nestle	76.36	0.69 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	78.00	0.49 %	K V
Roche Hldg G	252.50	0.44 %	K V
CieFinRichemont	121.90	-0.37 %	K V
Sika	226.60	-0.87 %	K V
ABB	49.02	-1.05 %	K V
Lonza Grp	517.00	-2.64 %	K V
Logitech Intl	70.06	-2.67 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Nam Tai Property Inc

Aktien Top/Flop

Meistgelesene Nachrichten